HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Shi Selected Research

Experimental Nervous System Autoimmune Disease

1/2022Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-κB pathways in experimental autoimmune myositis mice.
1/2017Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Shi Research Topics

Disease

115Neoplasms (Cancer)
08/2022 - 09/2002
76Hepatocellular Carcinoma (Hepatoma)
10/2022 - 06/2002
23Infections
03/2022 - 12/2004
21Inflammation (Inflammations)
10/2022 - 09/2006
20Neoplasm Metastasis (Metastasis)
09/2021 - 05/2002
18Breast Neoplasms (Breast Cancer)
08/2021 - 06/2006
10Chronic Hepatitis B
01/2021 - 11/2006
10Carcinogenesis
01/2021 - 07/2006
9Liver Cirrhosis (Hepatic Cirrhosis)
12/2021 - 03/2007
9COVID-19
02/2021 - 01/2020
9Fibrosis (Cirrhosis)
01/2021 - 07/2005
9Hepatitis B
10/2020 - 12/2004
8Multiple Myeloma
10/2022 - 10/2019
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 01/2018
8Ischemic Stroke
01/2020 - 01/2012
7Ischemia
01/2021 - 02/2011
7Carcinoma (Carcinomatosis)
03/2019 - 01/2006
6Liver Neoplasms (Liver Cancer)
01/2022 - 09/2002
6Thrombosis (Thrombus)
01/2019 - 09/2002
5End Stage Liver Disease
10/2022 - 03/2012
5Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 11/2018
5Prostatic Neoplasms (Prostate Cancer)
08/2022 - 01/2012
5Cytokine Release Syndrome
01/2022 - 01/2020
5Wounds and Injuries (Trauma)
01/2022 - 07/2008
5Leukemia
01/2022 - 05/2011
5Disease Progression
01/2021 - 07/2006
5Brain Ischemia (Cerebral Ischemia)
01/2020 - 10/2012
5Liver Diseases (Liver Disease)
10/2016 - 01/2011
5Stomach Neoplasms (Stomach Cancer)
10/2016 - 10/2010
5Stroke (Strokes)
05/2016 - 02/2011
4Body Weight (Weight, Body)
01/2022 - 12/2005
4Hepatitis
01/2022 - 12/2004
4Neuroinflammatory Diseases
01/2022 - 01/2018
4Thrombocytopenia (Thrombopenia)
01/2021 - 01/2018
4Hypoxia (Hypoxemia)
01/2020 - 06/2006
4Neoplasm Micrometastasis
12/2006 - 05/2002
3Parkinson Disease (Parkinson's Disease)
07/2022 - 01/2021
3Insulin Resistance
02/2022 - 12/2010
3Pain (Aches)
07/2021 - 03/2006

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
10/2020 - 03/2006
19Chimeric Antigen ReceptorsIBA
10/2022 - 01/2018
18DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2006
18Messenger RNA (mRNA)IBA
01/2022 - 01/2008
17Biomarkers (Surrogate Marker)IBA
06/2021 - 07/2006
14CytokinesIBA
10/2022 - 06/2002
12MicroRNAs (MicroRNA)IBA
06/2021 - 06/2009
11Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022 - 01/2018
11AntigensIBA
01/2022 - 01/2005
10Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 01/2018
10Leucovorin (Folinic Acid)FDA Link
10/2022 - 01/2018
10ginsenoside RdIBA
01/2020 - 02/2011
9Neuroprotective AgentsIBA
01/2022 - 01/2012
9Antiviral Agents (Antivirals)IBA
01/2022 - 07/2006
9Biological ProductsIBA
01/2021 - 03/2005
8Glucose (Dextrose)FDA LinkGeneric
02/2022 - 04/2014
8Sorafenib (BAY 43-9006)FDA Link
10/2021 - 01/2016
8alpha-Fetoproteins (alpha-Fetoprotein)IBA
09/2021 - 09/2006
8Pharmaceutical PreparationsIBA
01/2021 - 08/2004
7Therapeutic UsesIBA
02/2022 - 03/2007
6RNA (Ribonucleic Acid)IBA
03/2022 - 03/2014
6Capsules (Microcapsules)IBA
01/2021 - 09/2002
5Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 02/2004
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
5Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 06/2011
5BilirubinIBA
09/2021 - 02/2011
5CatecholaminesIBA
12/2020 - 10/2010
5Small Interfering RNA (siRNA)IBA
01/2020 - 10/2010
5Peptides (Polypeptides)IBA
01/2019 - 12/2007
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014 - 04/2006
4Long Noncoding RNAIBA
08/2022 - 01/2019
4InterferonsIBA
03/2022 - 01/2017
4ChemokinesIBA
01/2022 - 02/2003
4LigandsIBA
01/2022 - 10/2014
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 12/2010
4ArsenicIBA
06/2021 - 01/2018
4arseniteIBA
06/2021 - 01/2018
4InflammasomesIBA
01/2021 - 01/2019
4Hepatitis B e AntigensIBA
01/2021 - 11/2006
4Oxygen (Dioxygen)IBA
01/2020 - 07/2015
4Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 08/2010
4Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2018 - 10/2010
4Adrenergic Agents (Adrenergic Drugs)IBA
01/2018 - 10/2010
3bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
10/2022 - 10/2019
3B-Cell Maturation AntigenIBA
10/2022 - 10/2019
3Ethiodized Oil (Ethiodol)FDA Link
10/2022 - 04/2011
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2022 - 06/2015
3AntibodiesIBA
01/2022 - 07/2016
3Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2018
3AlbuminsIBA
09/2021 - 01/2019
3Insulin (Novolin)FDA Link
06/2021 - 12/2010

Therapy/Procedure

48Therapeutics
02/2022 - 04/2004
28Drug Therapy (Chemotherapy)
10/2022 - 08/2004
16Immunotherapy
01/2022 - 05/2003
12Hepatectomy
11/2018 - 05/2002
11Transplantation
01/2021 - 12/2010
5Radiotherapy
01/2022 - 04/2008
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2014 - 02/2010
4Renal Dialysis (Hemodialysis)
02/2021 - 01/2013
3Art Therapy
03/2022 - 01/2021
3Liver Transplantation
12/2021 - 03/2012